Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Int J Nurs Stud ; 140: 104447, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-36796118

RESUMEN

BACKGROUND: Lung cancer is one of the most common cancers and poses a physical and psychological threat to patients. Mindfulness-based interventions are emerging forms of psychotherapy that are effective in improving physical and psychological symptoms, but no review has summarized their effectiveness on anxiety, depression, and fatigue in people with lung cancer. OBJECTIVES: To evaluate the effectiveness of mindfulness-based interventions in reducing anxiety, depression, and fatigue in people with lung cancer. DESIGN: Systematic review and meta-analysis. METHODS: We searched the PubMed, Web of Science, Embase, China Biology Medicine disc, Wanfang Data, China National Knowledge Infrastructure, and China Science and Technology Journal databases from inception to 13 April 2022. Eligible studies included randomized controlled trials of people with lung cancer receiving mindfulness-based interventions reporting on the outcomes of anxiety, depression, and fatigue. Two researchers independently reviewed the abstracts and full texts, extracted the data and assessed the risk of bias independently by using the Cochrane 'Risk of bias assessment tool'. The meta-analysis was performed by using Review Manager 5.4, and the effect size was calculated by the standardized mean difference and its 95% confidence interval. RESULTS: The systematic review included 25 studies (2420 participants), whereas the meta-analysis included 18 studies (1731 participants). Mindfulness-based interventions significantly decreased levels of anxiety [standardized mean difference = -1.15, 95% confidence interval (-1.36, -0.94), Z = 10.75, P < 0.001], depression [standardized mean difference = -1.04, 95% confidence interval (-1.60, -0.48), Z = 3.66, P < 0.001], and fatigue [standardized mean difference = -1.29, 95% confidence interval (-1.66, -0.91), Z = 6.79, P < 0.001]. The subgroup analysis indicated that programs lasting less than eight weeks in length with structured intervention components (e.g., mindfulness-based stress reduction and mindfulness-based cognitive therapy) and 45 min of daily home practice implemented in patients with advanced stage lung cancer showed better effects than programs lasting more than eight weeks in length with less structured components and more than 45 min of daily home practice implemented in patients with mixed stage lung cancer. The overall quality of the evidence was low due to the lack of allocation concealment and blinding and the high risk of bias in most studies (80%). CONCLUSIONS: Mindfulness-based interventions might be effective in reducing anxiety, depression, and fatigue in people with lung cancer. However, we cannot draw definitive conclusions because the overall quality of the evidence was low. More rigorous studies are needed to confirm the effectiveness and examine which intervention components may be most effective for improved outcomes.


Asunto(s)
Neoplasias Pulmonares , Atención Plena , Humanos , Ansiedad/terapia , Depresión/terapia , Fatiga/terapia , Fatiga/etiología , Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/terapia , Calidad de Vida
2.
J Sep Sci ; 42(15): 2534-2549, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31144455

RESUMEN

A simple and sensitive liquid chromatography with tandem mass spectrometry method was developed for simultaneous quantification of paeoniflorin, albiflorin, oxypaeoniflorin, liquiritin, liquiritigenin, glycyrrhetinic acid, and glycyrrhizin in rat plasma after oral administration of Shaoyao-Gancao decoction, which is traditionally used in the treatment of polycystic ovary syndrome. The plasma samples were pretreated with methanol as precipitant. The method exhibited good linearity (correlation coefficient (R2 ) > 0.99) with lower quantification limits of 0.595-4.69 ng/mL for all analytes. Intra- and interbatch precision, accuracy, recovery, and stability of the method were all within accepted criteria. The results showed that the pharmacokinetic behaviors of the seven compounds were altered in the pathological status of polycystic ovary syndrome. Furthermore, a total of 36 metabolites were structurally identified based on their accurate masses and fragment ions. The major metabolic pathway involves phase I metabolic reactions (such as hydroxylation), phase II metabolic reactions (such as sulfation and glucuronidation conjugation) as well as the combined multiple-step metabolism. This study is the first report on the pharmacokinetic and metabolic information of Shaoyao-Gancao decoction in both normal and model rats, which would provide scientific evidences for the bioactive chemical basis of herbal medicines and also promote the clinical application of Shaoyao-Gancao decoction for treating polycystic ovary syndrome.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Síndrome del Ovario Poliquístico/tratamiento farmacológico , Administración Oral , Animales , Hidrocarburos Aromáticos con Puentes/sangre , Hidrocarburos Aromáticos con Puentes/metabolismo , Hidrocarburos Aromáticos con Puentes/farmacocinética , Cromatografía Líquida de Alta Presión , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/análisis , Medicamentos Herbarios Chinos/metabolismo , Medicamentos Herbarios Chinos/farmacocinética , Femenino , Flavanonas/sangre , Flavanonas/metabolismo , Flavanonas/farmacocinética , Glucósidos/sangre , Glucósidos/metabolismo , Glucósidos/farmacocinética , Ácido Glicirretínico/sangre , Ácido Glicirretínico/metabolismo , Ácido Glicirretínico/farmacocinética , Ácido Glicirrínico/sangre , Ácido Glicirrínico/metabolismo , Ácido Glicirrínico/farmacocinética , Monoterpenos/sangre , Monoterpenos/metabolismo , Monoterpenos/farmacocinética , Ratas , Ratas Sprague-Dawley , Espectrometría de Masas en Tándem
3.
Biosci Rep ; 39(1)2019 01 31.
Artículo en Inglés | MEDLINE | ID: mdl-30573529

RESUMEN

Shaoyao-Gancao Decoction (SGD) has been widely used for the treatment of gynopathy. The present study aimed to evaluate the therapeutic effect and potential mechanism of SGD on hyperandrogenism in polycystic ovary syndrome (PCOS) rats. In the present work, SGD was orally administrated to the PCOS rats at the dose of 12.5, 25, and 50 g/kg/d for 14 consecutive days. UPLC-MS/MS was performed to identify the main chemical components of SGD. Body weight, ovarian weight, cystic dilating follicles, and serum levels of steroid hormones were tested to evaluate the therapeutic effect of SGD. In order to further clarify the underlying mechanism, we also measured mRNA and the protein levels of NF-κB, NF-κB p65, P-NF-κB p65, and IκB by RT-qPCR and Western blotting techniques. Our results showed that SGD treatment significantly alleviated hyperandrogenism in PCOS rats as evidenced by reduced serum levels of T and increased E2 and FSH levels. In addition, SGD effectively reduced the phosphorylation of NF-κB p65 and increased the expression of IκB. Results of the present study demonstrated that SGD could ameliorate hyperandrogenism in PCOS rats, and the potential mechanism may relate to the NF-κB pathway.


Asunto(s)
Medicamentos Herbarios Chinos/administración & dosificación , Hiperandrogenismo/tratamiento farmacológico , FN-kappa B/genética , Síndrome del Ovario Poliquístico/tratamiento farmacológico , Animales , Modelos Animales de Enfermedad , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Hiperandrogenismo/inducido químicamente , Hiperandrogenismo/genética , Hiperandrogenismo/patología , Quinasa I-kappa B/genética , Letrozol/toxicidad , Síndrome del Ovario Poliquístico/inducido químicamente , Síndrome del Ovario Poliquístico/genética , Síndrome del Ovario Poliquístico/patología , Ratas , Factor de Transcripción ReIA/genética
4.
West J Nurs Res ; 38(2): 155-68, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25248661

RESUMEN

The purpose of this study was to evaluate the impact of progressive muscle relaxation on state anxiety and self-efficacy in hospitalized patients admitted for an extremity fracture receiving elective surgery. Eighty four patients met the inclusion criteria and all were randomly assigned to either the progressive muscle relaxation group or the control group. The control group received standard orthopedic nursing care, and the experimental group received standard care along with daily progressive muscle relaxation throughout their hospitalization. The State Anxiety Inventory and Self-Efficacy Scales were administered before and after the intervention. Both paired-sample t tests and independent t tests showed that progressive muscle relaxation is effective in reducing state anxiety and enhancing the self-efficacy of patients with extremity fracture undergoing an elective surgery.


Asunto(s)
Ansiedad/prevención & control , Fracturas Óseas/psicología , Terapia por Relajación/métodos , Autoeficacia , Estrés Psicológico/prevención & control , Adulto , Anciano , Femenino , Fracturas Óseas/rehabilitación , Fracturas Óseas/cirugía , Humanos , Masculino , Persona de Mediana Edad , Relajación Muscular , Calidad de Vida
5.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 34(3): 297-302, 2014 Mar.
Artículo en Chino | MEDLINE | ID: mdl-24758080

RESUMEN

OBJECTIVE: To explore the association between C825T polymorphism of G protein beta3 subunit (GNB3) gene and different Hilit types of essential hypertension (EH) in the Uygur nationality of Xinjiang. METHODS: According to Uygur medical theories, EH patients (as the EH group) and non-EH patients (as the control group) were assigned to four Hilit groups. The C825T polymorphism of GNB3 was detected in 161 EH patients and 379 non-EH subjects of different Hilit types by using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) to explore the difference of the genotypes and allelic frequencies and hypertension. RESULTS: (1) In Xinjiang Uygur population, the distribution frequencies of GNB3 C825T polymorphism were in accordance with Hardy-Weinberg (chi2 = 0.871, P = 0.647). (2) There was no statistical difference in the distribution frequencies of three genotypes and two alleles of GNB3 between the EH group and the control group (P > 0.05). (3) There was statistical difference in distribution frequencies of three genotypes between the abnormal Sapra and non-abnormal Sapra group (the sum of abnormal Sewda, abnormal Kan, and abnormal Balhem) (chi2 = 6.905, P = 0.032), especially between the abnormal Sapra and abnormal Balhem groups (chi2 = 10.404, P = 0.006), but there was no statistical difference in distribution frequencies of alleles between the two groups (P > 0.05). (4) In 161 EH patients, there was statistical difference in the distribution frequencies of three genotypes and two alleles between the abnormal Sapra and non-abnormal Sapra group (chi2 = 9.034, P = 0.011; chi2 = 4.701, P = 0.03). CONCLUSIONS: Both TT genotype and T allele of GNB3 C825T polymorphism might not be associated with EH patients in Xinjiang Uygur populations. However, they were correlated with hypertension patients of non-abnormal Sapra, indicating the pathogeneses of EH with different Hilit types might be different.


Asunto(s)
Proteínas de Unión al GTP Heterotriméricas/genética , Hipertensión/clasificación , Hipertensión/genética , Medicina Tradicional China , Polimorfismo Genético , Adulto , Anciano , Alelos , Estudios de Casos y Controles , Hipertensión Esencial , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Hipertensión/diagnóstico , Masculino , Persona de Mediana Edad , Grupos Minoritarios
6.
Environ Technol ; 31(1): 53-61, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20232679

RESUMEN

Activated carbon was produced by fast precarbonization of cornstalk lignin in a fluidized bed followed by K2CO3 activation. The results showed that the product is essentially microporous carbon whose Brunauer-Emmett-Teller surface area and pore volume when the carbon was activated at 800 degrees C were 1410 m2/g and 0.77 mL/g, respectively. The potential usefulness of the resultant carbons for removal of phenol from water and their subsequent bioregeneration capabilities were also investigated. The kinetics study showed that all the carbons exhibited a fast adsorption rate and the carbon activated at 800 degrees C had the largest amount of phenol adsorbed due to its greater specific surface area and pore volume. The adsorption isotherms by applying the Langmuir method showed that the monolayer adsorption capacity of carbon activated at 800 degrees C could reach 110.9 mg/g.


Asunto(s)
Reactores Biológicos/microbiología , Carbonatos/química , Carbón Orgánico/síntesis química , Lignina/química , Fenol/aislamiento & purificación , Fenol/metabolismo , Potasio/química , Zea mays/química , Absorción , Biodegradación Ambiental , Componentes Aéreos de las Plantas/química , Extractos Vegetales/química , Ultrafiltración/métodos
7.
Arch Environ Contam Toxicol ; 57(2): 256-63, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19125218

RESUMEN

Water chestnut is one of the most popular vegetables in Asian countries that grows in shallow water. Eighteen water chestnut samples were collected from Lake Tai and six samples were bought at markets in Wuxi, China, in October 2007. Extraction solution of water chestnut was cleaned up with a solid phase extraction column and immunoaffinity chromatography cartridges, then the microcystin (MC) level was detected by indirect competitive enzyme-linked immunosorbent assay (ELISA) and liquid chromatography-mass spectrometry (LC-MS). The results of ELISA showed that there were six samples collected from Lake Tai which contained MCs; the highest level of total MCs was 7.02 ng/g. The results of LC-MS confirmed that MC-LR and MC-RR were present in five samples. The highest level of MC-LR was 1.02 ng/g and that of MC-RR was 4.44 ng/g. Heavy cyanobacterial blooms had occurred, and MCs were detected in water at the points in Lake Tai where MCs occurred in water chestnuts collected in 2007. MCs were not detected in the six samples bought at Wuxi markets. The results suggest that MCs can accumulate in water chestnuts, which is a potential hazard for human health.


Asunto(s)
Cianobacterias/química , Eleocharis/química , Eutrofización , Microcistinas/análisis , Anticuerpos Monoclonales/química , Cromatografía Líquida de Alta Presión , Ensayo de Inmunoadsorción Enzimática , Espectrometría de Masas , Extractos Vegetales/análisis
8.
Phytother Res ; 23(6): 844-50, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19117333

RESUMEN

Ganoderma sinensis has been used widely in Oriental countries for the prevention and treatment of various diseases including cancer. Previous studies have shown that the lipid extract from Ganoderma exhibits direct cytotoxicity against tumor cells. Here, it is reported that the lipid extract from germinating G. sinensis spores, at lower concentrations that have no direct tumoricidal activity, induce potent antitumor immune responses in human monocytes/macrophages. Upon stimulation with the lipid extract, monocytes/macrophages exhibited markedly increased production of proinflammatory cytokines and surface expression of costimulatory molecules. Conditioned medium from stimulated cells effectively suppressed the growth of tumor cells. Apparently, the lipid extract triggered macrophage activation via a mechanism different from that associated with LPS. Moreover, it was observed that the lipid extract could partially re-establish the antitumor activity of the immunosuppressive tumor-associated macrophages. These results indicated that in addition to its direct tumoricidal activity, the lipid extract from G. sinensis spores could exert antitumor activity by stimulating the activation of human monocytes/macrophages.


Asunto(s)
Citotoxicidad Inmunológica/efectos de los fármacos , Ganoderma/química , Lípidos/farmacología , Macrófagos/inmunología , Monocitos/inmunología , Adyuvantes Inmunológicos/farmacología , Antineoplásicos/farmacología , Proliferación Celular , Células Cultivadas , Citocinas/metabolismo , Humanos , Macrófagos/efectos de los fármacos , Monocitos/efectos de los fármacos , Triterpenos/farmacología , Células U937
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA